,,ii #aahth ,,congress #ast ,session ,s4 #cdaa ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,december #e1 #bjbc,mr4 ,peters introduced the following bill2 which was read twice and referred to the ,committee on ,homeland ,security and ,governmental ,affairs ,a ,,bill ,to prohibit contracting with certain biotechnology providers4 #a4 ,short title ,this ,act may be cited as the ,safeguarding ,american ,genetic ,data ,act of #bjbc4 #b4 ,prohibition on contracting with certain biotechnology providers 7a7 ,designation of ,federal entity ,not later than #cj days after the date of the enactment of this ,act1 the ,president shall designate a ,federal entity 7in this section referred to as the ,federal entity7 to establish guidance to ensure that ,executive agencies do not directly procure or obtain any covered biotechnology equipment or service4 ,the ,federal entity1 the head of which shall be the ,director of the ,office of ,management and ,budget1 shall include the ,secretary of ,defense1 the ,attorney ,general1 the ,secretary of ,health and ,human ,services1 the ,secretary of ,commerce1 the ,director of ,national ,intelligence1 the ,secretary of ,homeland ,security1 the ,secretary of ,state1 and the heads of other appropriate ,federal agencies as identified by the ,president4 7b7 ,policy1 guidance1 and regulations 7#a7 ,recommendations ,not later than one year after the date of the enactment of this ,act1 the ,federal entity1 in coordination with the ,federal ,acquisition ,regulatory ,council and other heads of ,executive agencies as determined appropriate by the ,president1 shall issue guidance and recommend the establishment of policy and regulations1 as necessary1 to implement the requirements of this section4 7#b7 ,,omb policy ,not later than #ahj days after the date of issuance of recommendations under paragraph 7#a71 the ,director of the ,office of ,management and ,budget shall issue any policy necessary to effectuate the recommendations4 7#c7 ,federal acquisition regulation ,not later than one year after the date of issuance of recommendations under paragraph 7#a71 the ,federal ,acquisition ,regulatory ,council shall revise the ,federal ,acquisition ,regulation as necessary to implement the requirements of this section4 7#d7 ,effective date ,any prohibition included in the guidance established by the ,federal entity in accordance with paragraph 7#a7 shall take effect not later than one year after the establishment of such guidance4 7c7 ,rule of construction ,nothing in this section shall be construed-- 7#a7 to require any covered biotechnology equipment or service in use or resident in equipment1 systems1 or services as of the day before the applicable effective date specified in subsection 7b77#d7 to be removed or replaced2 or 7#b7 to prohibit or limit the utilization of such covered biotechnology equipment or service throughout the lifecycle of such existing equipment4 7d7 ,exceptions ,any prohibition included in the guidance established by the ,federal entity under subsection 7b7 shall not apply to-- 7#a7 any activity subject to the reporting requirements under title ,v of the ,national ,security ,act of #aidg 7#ej ,u4,s4,c4 #cjia et seq47 or any authorized defense or intelligence activities of the ,united ,states ,government2 7#b7 health care services and related equipment and supplies for-- 7,a7 employees of the ,united ,states ,government1 including members of the uniformed services 7as that term is defined in section #aja7;a7 of title #aj1 ,united ,states ,code71 whose official duty stations are located overseas or are on permissive temporary duty travel outside of the continental ,united ,states2 or 7,b7 employees of contractors or subcontractors of the ,united ,states-- 7i7 who are performing under a contract that directly supports the missions or activities of individuals described in subparagraph 7,a72 and 7ii7 whose official duty stations are located overseas or are on permissive temporary duty travel outside of the continental ,united ,states4 7#c7 the acquisition1 use1 or distribution of multiomic data1 however compiled1 that is commercially or publicly available4 7e7 ,waiver authorities 7#a7 ,in general ,the policy1 guidance1 and regulations established under subsection 7b7 shall allow the head of an ,executive agency to waive any prohibition implemented in connection with such guidance on a case-by-case basis after consultation with the ,federal entity4 7#b7 ,duration 7,a7 ,in general ,except as provided in subparagraph 7,b71 a waiver granted under paragraph 7#a7 shall last for a period of not more than one year4 7,b7 ,extension ,the head of an ,executive agency may extend a waiver granted to an ,executive agency under paragraph 7#a7 one time1 for a period up to #ahj days after the date on which the waiver would otherwise expire1 if such an extension is in the national security interests of the ,united ,states and the ,executive agency submits to the appropriate congressional committees a notification of such waiver not later than #cj days after granting the waiver4 7f7 ,determination of certain biotechnology entities 7#a7 ,in general ,not later than #ahj days after the date of the enactment of this ,act1 the ,federal entity shall develop a list of entities determined to be a biotechnology company of concern4 ,the ,federal entity shall define a biotechnology company of concern as any entity that-- 7,a7 is subject to the jurisdiction1 direction1 control1 or operates on behalf of the government of a foreign adversary2 7,b7 is to any extent involved in the manufacturing1 distribution1 provision1 or procurement of biotechnology equipment or services2 and 7,c7 poses a risk to the national security of the ,united ,states based on-- 7i7 engaging in joint research with1 being supported by1 or being affiliated with a foreign adversary's military1 internal security forces1 or intelligence agencies2 7ii7 providing multiomic data obtained via biotechnology equipment or services to the government of a foreign adversary2 or 7iii7 obtaining human multiomic data via biotechnology equipment or services without expressed and informed consent4 7#b7 ,updates ,the ,federal entity shall periodically1 but not less than annually1 review and1 as appropriate1 modify the list of biotechnology companies of concern4 7g7 ,evaluation of certain biotechnology entities ,not later than #ahj days after the date of the enactment of this ,act1 the ,federal entity shall determine whether ,,bgi1 ,,mgi1 ,complete ,genomics1 and any subsidiary1 affiliate1 or successor of such entities1 are biotechnology companies of concern4 ,if any such entities1 subsidiaries1 affiliates1 or successors are identified as biotechnology companies of concern1 no ,executive agency shall directly procure or obtain any biotechnology equipment or services from such entities1 subsidiaries1 affiliates1 or successors4 ,the ,director of the ,office of ,management and ,budget shall issue such policy1 and the ,federal ,acquisition ,regulatory ,council shall promulgate such regulations1 as may be necessary to effectuate this prohibition4 7h7 ,analysis1 assessment1 and strategy ,not later than #ahj days after developing the list of entities under subsection 7f77#a7 and the determination of entities under subsection 7g71 the ,federal entity1 to the greatest extent practicable1 leveraging relevant previous analyses and assessments1 shall-- 7#a7 conduct an analysis of the list of entities identified under subsections 7f77#a7 and 7g71 including-- 7,a7 active ,federal grants to or contracts with private companies1 academic institutions1 and public sector entities1 including-- 7i7 the number and type of covered biotechnology equipment or services already or expected to be procured2 7ii7 the anticipated lifespan of covered biotechnology equipment or services already or expected to be procured2 7iii7 the estimated costs and timeline to replace covered biotechnology equipment or services already procured2 and 7,b7 the domestic and international market share2 7#b7 assess risks to national security posed by the entities identified under subsections 7f77#a7 and 7g71 obtaining active and future ,federal grants to or contracts with private companies1 academic institutions1 and public sector entities2 7#c7 develop a strategy to-- 7,a7 mitigate the risks to national security identified in the assessment conducted under paragraph 7#b72 and 7,b7 support private companies1 academic institutions1 and public sector entities seeking to acquire covered biotechnology equipment or services from alternative entities2 and 7#d7 provide the results of the analysis1 assessment1 and strategy developed under this subsection to the ,federal ,acquisition ,regulatory ,council and the appropriate congressional committees4 7i7 ,report requirement 7#a7 ,in general ,not later than #ahj days after the date of the enactment of this ,act1 the ,federal entity shall submit to the ,federal ,acquisition ,regulatory ,council and the appropriate congressional committees a report including the following3 7,a7 ,the name of and justification for each entity meeting the criteria for a biotechnology company of concern under subsections 7f77#a7 and 7g74 7,b7 ,a catalog of all active or planned grants or contracts any ,executive agency has with any entity determined to be a biotechnology company of concern related to biotechnology equipment or services4 7,c7 ,recommendations1 as applicable1 on alternative entities to a biotechnology company of concern capable of providing the ,federal ,government with required biotechnology equipment or services4 7,d7 ,recommendations1 as applicable1 on the feasibility of implementing prohibitions implemented in connection with the guidance established under subsection 7b7 or exercising waiver authorities under subsection 7e71 to ensure uninterrupted ,federal ,government access to required biotechnology equipment and services1 and any further changes to legislation needed to mitigate supply chain risks or increase availability and enhance capabilities of biotechnology equipment and services4 7#b7 ,form ,the report required under paragraph 7#a7 shall be in unclassified form accompanied by a classified annex4 7j7 ,definitions ,in this section3 7#a7 ,appropriate congressional committees ,the term appropriate congressional committees means-- 7,a7 the ,committee on ,armed ,services1 the ,committee on ,commerce1 ,science1 and ,transportation1 the ,committee on ,foreign ,relations1 the ,committee on ,health1 ,education1 ,labor1 and ,pensions1 and the ,committee on ,homeland ,security and ,governmental ,affairs of the ,senate2 and 7,b7 the ,committee on ,armed ,services1 the ,committee on ,foreign ,affairs1 the ,committee on ,oversight and ,accountability1 the ,committee on ,energy and ,commerce1 and the ,select ,committee on ,strategic ,competition between the ,united ,states and the ,chinese ,communist ,party of the ,house of ,representatives4 7#b7 ,biotechnology equipment or service ,the term biotechnology equipment or service means-- 7,a7 equipment1 including genetic sequencers1 mass spectrometers1 polymerase chain reaction machines1 or any other instrument1 apparatus1 machine1 or device1 including components and accessories thereof1 that is designed for use in the research1 development1 production1 or analysis of biological materials1 as well as any software1 firmware1 or other digital components that are specifically designed for use in1 and necessary for the operation of1 such equipment2 7,b7 any service for the research1 development1 production1 analysis1 detection1 or provision of information1 including data storage and transmission1 related to biological materials1 including-- 7i7 advising1 consulting1 or support services provided by a biotechnology company of concern with respect to the use or implementation of an instrument1 apparatus1 machine1 or device described in subparagraph 7,a72 or 7ii7 disease detection1 genealogical information1 and related services2 and 7,c7 any other service1 instrument1 apparatus1 machine1 component1 accessory1 device1 software1 or firmware that the ,federal entity determines appropriate4 7#c7 ,control ,the term control has the meaning given the term in section #hjj4bjh of title #ca1 ,code of ,federal ,regulations1 or any successor regulations4 7#d7 ,covered biotechnology equipment or service ,the term covered biotechnology equipment or service means a biotechnology equipment or service produced or provided by a biotechnology company of concern4 7#e7 ,executive agency ,the term ,executive agency has the meaning given the term in section #aje of title #e1 ,united ,states ,code4 7#f7 ,foreign adversary ,the term foreign adversary has the meaning given the term covered nation in section #dhgb7;d7 of title #aj1 ,united ,states ,code4 7#g7 ,multiomic ,the term multiomic means data types that include genomics1 epigenomics1 transcriptomics1 proteomics1 and metabolomics4 7#h7 ,overseas ,the term overseas means any area outside of the ,united ,states1 the ,commonwealth of ,puerto ,rico1 or a territory or possession of the ,united ,states4